Toggle navigation
Home
Search
Services
Blog
Contact
About
Peroxisome Biogenesis, Normal and Deficient
Balfe, Alan M.
Kennedy Krieger Research Institute, Inc., Baltimore, MD, United States
Search grants from Alan Balfe
Search grants from Kennedy Krieger Research Institute, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Distance-Dependent Structure and Function of Neuronal Dendrites
New York's Schip: What Works for Vulnerable Children
CORE - Mechanisms of toxicity and cell death
Lesions Effects on Visual Perception of Motion
CSR-EHCS(EHS), TM: Distributed Sensing via Robust Consensus on Manifolds
Recently added grants:
Role of SLIT-ROBO and MT1-MMP in MSC-Mediated Neovascularization.
Role of ASC in TBI-Mediated Systemic Inflammation.
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
Hypertension in Adult IUGR Offspring: Beneficial Effects of Perinatal Intervention
An adolescent sensitive period for thalamo-prefrontal circuit maturation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
1F05TW003908-01
Application #
3021253
Study Section
(BI)
Project Start
1988-06-30
Project End
Budget Start
1987-11-01
Budget End
1988-10-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Kennedy Krieger Research Institute, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Related projects
NIH 1989
F05 TW
Peroxisome Biogenesis, Normal and Deficient
Balfe, Alan M. / Kennedy Krieger Research Institute, Inc.
NIH 1987
F05 TW
Peroxisome Biogenesis, Normal and Deficient
Balfe, Alan M. / Kennedy Krieger Research Institute, Inc.
Publications
Watkins, P A; Chen, W W; Harris, C J et al.
(1989)
Peroxisomal bifunctional enzyme deficiency.
J Clin Invest 83:771-7
Comments
Be the first to comment on this grant